Document vVxMwgdv51OMYxjpjnmMe9ELE

v pulmonary fltitioi: testing tZZZZUQ AT HASKELL LABORATORY OCTOBER 25# 1955 Topics; Asbestos Problans Pulmonary Probleaa Relation of Serur. nickel in Myocardial Infarction" ' Menbers In Attendance: C. A. D'Aicnto, H.D. J. A. Zapp, Jr., Ph.D. J* Ri Zehn, MiD* J. V. Cieytcn, Ph.D. C. F. Reinhardt, M.D. \ .................... .......... 'T` . .<- ` - / S. Pell, Ph.D., - / A. L. LinctT w s Kaeld, Jr., M.JD. G. J. StcppfT'-M.-Df'' V. K. Zane (Engr.-Lcuviers) Asbestcsis Objectives were outlined. Mode of achieving objectives. Application of findings once obtained. Distribution of application. Objectives . Exposure 1. Define Exposure Levels Responsibility of Engineering Service Division 2. Exeslne Types of Operations Involved Responsibility of Engineering Design. 3. Detemine Adequate Respiratory Protection Responsibility of Ecsfcell Laboratory 4. . Investigate Insulating Materials ' Vhat was used in past. Vhct is ussd now. v What suitable substitutes available. Responsibility of Engineering Design. ^ 055 SC-DP-01475 1. Review record* of *11 Company cases of mesothelioma - end lung cancer. 2. Questionnaire to ?lent Sites Re: Lung Cancer . Snoring History - 3. Revise Company history end physicei excninction cards. Include goad smoking and alcohol history. Pulmonary disease disclosure. Chest x-ray. Functional studies. 5. Establish Company Industrial Hygiene Central Department Pulmonary Function Utilize Pulnonor Machine Determine which tests" give best applicable results: . Forced Expiratory Rate Yltel Capacity Timed Vital Capacity Vor* with Dr. C. Reinhardt Vielt with Dr. Toaashefs:-! in Columbus, Chio, for intricacy of testing. Develop pre-testing questionnaire Wori; with Dr. C. Reinhcrdt end S. Pell Use C.W. es pilot plant . Re-eveluate results in approximately six months. If valuable., set up etenderds for entire Du Pont Co. utilization. dup 0900651 129565 Klc/.el (vith infarction) ' Reletio.. of Hichel Content with Myocardial Infarction Kicitel Study If * nev case of acute myocardial infarction i* determined, ve ere requested to obtain within the first Zk hours 10 dc. of sere (centrifuge sample) from the patient. Simultaneously, ve should draw e control sample fron e comparable subJoct--CGe, sex, height, weight, etc. Send both samples to Hcs.-.ell Lsborco or/ c/o Vi. Clayton, utilising letters for identification such es A, S, C, etc. Send pertinent information concerning the patient to Dr. C. A. D'Aicnco, Wilmington, Delev;are. vzrr/K-s 10-21-55 Copies: V. E. Neeld, Jr., M.D. C. Q. Young, M.D. K. R. Downs, M.D. E. Tillman, M.D. R. F. Minims, M.D. File DUP 0900652 J29566